Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDUH vs LMWH for VTE Prophylaxis in Major Trauma
NCT01729559Phase 4Completed
- Sponsor
- Scripps Health
- Start
- Nov 2012
- Primary completion
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in venous thromboembolism (VTE), sponsored by Scripps Health. Started Nov 2012; status: completed.
02
Drugs
heparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01729559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01729559.